That aroma of fraud: 70% of Bill de Blasio's local donors

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
208
That aroma of fraud: 70% of Bill de Blasio's
local donors come from one hotel union
< >

Is Bill de Blasio able to do anything honestly?

It's not enough that the Democratic presidential nominee has something like zero-percent support. He's got support all right, in New York City - from exactly one hotel workers' union, the 40,000-strong Hotel Trades Council ... and pretty much no one else. The union "owed" de Blasio for harrassing a rival, AirBNB, and there looks like some back scratching as a result. According to the New York Post:

In the subsequent weeks, some 4,600 hotel and hospitality workers gave a total of $89,000 to the campaign with the average donation being just under $20, according to the Center for Public Integrity campaign finance data reviewed by The Post.

As of June 30, he’d secured $1.1 million from a total of 6,700 donors.

Shortly after launching his long-shot White House bid in May, de Blasio told NY1 his campaign would have a “grassroots-focused approach.”

The Post reports that 70% of de Blasio's New York City support comes from this one hotel workers' union. And, to do the numbers, 4,000 of these 40,000, a whopping 10%, just couldn't help but shell out tiny less-than-$20 campaign donations because they were all just so grateful de Blasio harassed AirBNB?

Something smells a little rotten here, the smell of the Fulton Fish Market on mafia shakedown day. Seriously, we are supposed to think that that many slave-wage workers just couldn't help themselves and had to shell out for Bill, even as every other union in the city shows no such worker support? Even as smalltime donors are keeping away from de Blasio and the crime-filled mess he's made of New York? And these small-league de Blasio donors all did it so very spontaneously and voluntarily? How many of these workers were here illegally -- and by extension, were extremely easy to shake down, 'nice job you have here, be a shame if anything happened to it?' In the hotel industry, you can bet it was quite a few.

Coming from de Blasio, who says it's all very grassroots, this is rich. De Blasio in fact is no stranger to campaign corruption allegations. In 2017, according to this local CBS report, the feds were after him for exactly that:

The corruption probe by the FBI and U.S. Attorney Preet Bharara is looking into whether polices officers accepted lavish gifts and vacations in exchange for police escorts and security.

But the investigation also involves businessmen Jeremy Reichberg and Jona Rechnitz, who both served on de Blasio’s inaugural committee in 2013 and contributed to his campaign.

Now, sources told Kramer the feds are questioning people in the real estate industry about how the mayor raises money.

Sources said the questions from the U.S. Attorney’s office have focused on how donations are solicited by team de Blasio – including former campaign treasurer Ross Offinger.

When even Preet Brarara thinks you're corrupt, it's got to be pretty bad.

De Blasio's no stranger to other scandals either. There was that lost billion on his wife Chirlane McCray's educational initiative -- to this day no one knows where the money went, according to the Post's Bob McManus:

Fast-forward to Wednesday, when the City Council was startled to discover that McCray and Team Thrive are closing in on having spent an eye-popping $900 million since the program’s inception — and nobody seems to have a clue on what.

That is, nobody appears to have kept receipts; the subways and street corners are still overrun with crazy people, and nobody in charge knows what’s to happen next.

But let’s be clear: If your boondogglery sets the New York City Council back on its heels, you truly are soaring with the eagles.

Or this:

Right up there with co-Mayor Bill, who started the week on his own sour note — announcing that his signature Renewal school program was closing up shop after pounding $773 million down a rathole.

Well, he didn’t actually say “rathole,” and the price tag has doubtless been lowballed — but he also had no credible explanation for the debacle, nor did he apologize for it.

That's a whole lot of suspicious dealing around campaign finance, now showing up in this one very, very, very grateful hotel worker's union and all of its workers' sudden impulse to donate to de Blasio's campaign coffers.

The irony here is that Democratic Party chairman Tom Perez said that the Democrats were allowing so many clowns on stage precisely because they wanted the party to be transparent, to avoid the idea of favoritism in the picking of candidates which clouded their 2016 election turnout as Bernie Sanders got stiffed.

What that's really opened the door to is unworthy characters with zero support and long histories of campaign finance violations and corruption in general, to get on the stage, too. Instead of making the system better, it has been made better but only for corrupt people such as de Blasio.

Maybe it's time to investigate this weird campaign baloney coming from his campaign as corruption, too.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 5

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Enanta Pharmaceuticals Highlights Fiscal Q1 2025 Performance

Updated Category News Views 188

Enanta Pharmaceuticals Reports Financial Highlights for Q1 2025 Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology firm, has revealed its financial results for the first fiscal quarter ending December 31, 2024. This quarter is seen as a crucial period for the company as it expands its innovative drug portfolio targeting viral and immunological...

Continue Reading
Friedman Industries Reports Impressive First Quarter Growth

Updated Category News Views 98

Friedman Industries Reports Significant First Quarter Growth Friedman Industries, Incorporated (NASDAQ/GS: FRD) has announced remarkable results for the first quarter of the fiscal year, showcasing a strong performance that has positioned the company favorably in the steel manufacturing sector. The results released highlight not only the growth in earnings but also an...

Continue Reading
From Doubt to Delicious: The Rise of Raising Cane's

Updated Category News Views 308

Overcoming Doubt: The Birth of Raising Cane's The journey of Raising Cane's is not just about chicken fingers; it's a story of perseverance. Founded by Todd Graves, the chain has become a testament to how challenges can fuel passion and success. Graves faced significant skepticism from those who thought the concept was flawed due to its limited menu. Motivation Behind...

Continue Reading
Understanding Japan's Impact on US Tech Stock Dynamics

Updated Category News Views 371

The Influence of Japan's Real Rates on US Markets The current landscape of the S&P 500 bull market has been subject to various influences, and surprisingly, one of the most significant factors is not a domestic recession in the US but rather Japan's extraordinarily negative real interest rates compared to those in the US. This insightful perspective comes from BCA...

Continue Reading
Ocean Ledger Secures Funding to Enhance Coastal Risk Solutions

Updated Category News Views 171

Ocean Ledger Secures Funding for Coastal Risk Management Ocean Ledger, a promising geospatial analytics startup, has recently completed a successful funding round, securing $900K to enhance its capabilities in coastal risk management. This investment is poised to support the development of innovative solutions aimed at forecasting coastal risks, benefitting various...

Continue Reading